16:02 Dec 20
Aurobindo Pharma Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Aurobindo Pharma Ltd.
77/100 High Financial Strength
Quality58/100 Affordable Valuation
Valuation48/100 Technically Neutral
TechnicalSWOT
Strength
4
Weakness
3
Opportunity
1
Threat
2
72.76K
Market Cap (Cr)
20.14
PE Ratio
2.36
Price to Book Ratio
44.58
RSI
10.94 %
Net Profit Margin
Rating Based on 9 Analysts
Buy
67%
Hold
33%
Sell
0%
Buy
Analyst Price Target
The average price target is 1431.56 with a high estimate of 1591 and low estimate of 1120
Current 1241.70
Disclaimer:The analysis information is for reference only and does not constitude an investment recommendation
SWOT
Download Our App On:
